The Bio-Intelligence Revolution: Exploring the Intersection of High Tech & Biotech

TechSurge: Deep Tech Podcast

Content provided by Celesta Capital | Deep Tech Venture Capital Firm. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Celesta Capital | Deep Tech Venture Capital Firm or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

1+ y ago 50:03

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 11, 2025 17:51 (28d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Driven both by surging demand and rapid technology advancements, an emerging area of health innovation called “bioconvergence” is driving improvements in human health and sustained interest from investors. This episode will explore these new applications merging engineered technologies with scientific disciplines, including in diagnostics, therapeutics, and elsewhere.

Nobel Laureate Dr. Jim Rothman, Dr. Melanie Mathieu of Prellis Biologics, and Daniel Dornbusch of Excision join host Michael Marks for an in-depth discussion covering advancements in CRISPR technology, the role of AI in drug discovery, the future of personalized medicine, and much more.

26 episodes

#Tech #Celesta Capital | Deep Tech Venture Capital Firm #Trading #Business